发明名称 |
Long lasting drug formulations |
摘要 |
The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon alpha. |
申请公布号 |
AU2007294858(B2) |
申请公布日期 |
2011.05.12 |
申请号 |
AU20070294858 |
申请日期 |
2007.09.12 |
申请人 |
MEDGENICS MEDICAL ISRAEL, LTD |
发明人 |
ANDREW L. PEARLMAN |
分类号 |
A61K31/70;A61K48/00;A61P43/00;C07H21/04;C12N5/00;C12N15/00;C12N15/85 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|